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Abstract: The largest wastewater treatment plant in Jordan was monitored in the summer to determine the 
removal of pharmaceuticals and personal care products (PPCPs). Grab samples were collected from the influent 
and effluent of As-Samra Wastewater Treatment Plant (WWTP). Liquid chromatography and tandem mass 
spectrometry (LC–MS/MS) were utilized to determine the concentrations of 18 compounds of pharmaceuticals 
and personal care products (PPCPs). The results showed that 14 compounds were detected in the collected 
samples from the influent and effluent of As-Samra WWTP. These compounds are 1,7-dimethylxanthine, 
amphetamine, acetaminophen, caffeine, carbamazepine, cimetidine, cotinine, diphenhydramine, 
methylenedioxymethamphetamine (MDMA), morphine, phenazone, sulfamethazine, sulfamethoxazole, 
thiabendazole, and trimethoprim. However, four compounds were below the detection limit (<0.005 µg/L), 
namely cimetidine, methylenedioxyamphetamine (MDA), methamphetamine, and sulfachloropyridazine. 
Among PPCPs, the highest estimated average concentrations in raw wastewater were caffeine, acetaminophen, 
1,7-dimethylxanthine, cotinine, and carbamazepine sampled during the summer, at an estimated concentration 
of 155.6 µg/L, 36.7 µg/L, 10.49 µg/L, and 1.104 µg/L, respectively. However, the highest estimated average 
concentrations in treated wastewater were for carbamazepine, sulfamethoxazole, caffeine, cotinine, and 
acetaminophen, at 0.856 µg/L, 0.096 µg/L, 0.086 µg/L, 0.078 µg/L, and 0.041 µg/L, respectively. In general, the 
results showed that some compounds in the collected samples of wastewater in Jordan have concentrations 
exceeding the values reported in the literature. The removal efficiency rates of 1,7-dimethylxanthine, 
acetaminophen, caffeine, cotinine, morphine, and trimethoprim were higher than 95%, while those of 
carbamazepine, sulfamethazine, and sulfamethoxazole were lower than 22.5%. Moreover, diphenhydramine 
and thiabendazole had negative removal efficiency rates. The removal efficiency rates of the PPCPs in As-Samra 
WWTP were generally consistent with those of indicator compounds reported in the literature for conventional 
WWTPs. 
Keywords: pharmaceutical compounds; personal care products; wastewater treatment; activated 
sludge system; removal efficiency 
 
1. Introduction 
The main sources of emerging contaminants are pharmaceuticals and personal care products 
(PPCPs), endocrine disrupting chemicals (EDCs), plasticisers (e.g., bisphenol-A), flame-retardants, 
fuel additives, and other industrial organic products [1]. PPCPs have been detected in all 
environmental compartments, such as water, soil, air, biota, and wastewater at concentrations 
ranging from sub-ng/L levels to µg/L [2,3]. The presence of these compounds in the environment has 
been shown to result in adverse ecological and health risks for the exposed biota and humans, even 
at very low concentrations (ng/L range) [4–6]. However, the literature indicates that the currently 
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employed conventional wastewater treatment processes (primary and secondary) cannot not 
effectively eliminate all PPCPs in the raw wastewater [7–11]. Therefore, municipal wastewater 
treatment plants (WWTPs) are considered as a main source for the discharge of PPCPs into surface 
waters.  
With an increase in the contamination of waterways and water supply systems from these 
pollutants and the greater reliance on alternative water sources such as reuse of treated wastewater, 
it has become apparent that there is a need for further monitoring and research on the impact of 
PPCPs on the environment. Recent studies conducted in Europe, USA, and Canada have showed that 
the reuse of wastewater effluents (treated and untreated) can result in contamination of ground and 
surface water resources by PPCPs [5,12,13]. However, the research efforts made to address this issue 
in low-income countries (i.e., Jordan) are still lagging behind those in developed countries due to lack 
of monitoring of PPCP compounds in water resources as well as lack of availability of the analytical 
instruments and methods needed to identify PPCPs at low concentration levels (ng/L). 
Jordan is currently relying on treated wastewater as one of the main water sources for 
agricultural activities. About 95% of wastewater is treated, and more than 92% of treated wastewater 
is reused in agricultural activities, which is one of the highest percentages of reuse among the Arab 
countries [14]. According to a report published in 2018, there were 32 sewage WWTPs located in 
Jordanian cities. The estimated amount of treated wastewater discharged by these plants is about 166 
× 106 m3 [15]. As-Samra Wastewater Treatment Plant (WWTP) is considered the largest wastewater 
treatment facility in Jordan. It is currently serving the governorates of Amman and Zarqa, where a 
population of over 4 million people is growing rapidly. The plant treats annually more than 118 × 106 
m3 wastewater released from the Zarqa River basin and drains most of its effluent into the King Talal 
Dam, which provides irrigation water for most agricultural activities at Jordan Valley. The problem 
of emerging contaminants has not received enough attention in Jordan. There are limited studies 
examining the presence of PPCPs in the influent (raw wastewater) and effluent, and their removal 
from As-Samra WWTP. Therefore, as far as we know, this is the first study to cover this issue in 
Jordan. 
The objective of this study was to evaluate the occurrence of PPCPs in the largest wastewater 
treatment plant in Jordan (As-Samra WWTP, serving the cities of Amman and Zarqa) and to 
determine the removal efficiency rates of the tested compounds during the summer season. 
2. Materials and Methods 
2.1. As-Samra WWTP 
As-Samra Wastewater Treatment Plant (WWTP) is considered the largest wastewater treatment 
facility in Amman Zarqa Basin in Jordan. The location of the plant is shown in Figure 1. 
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Figure 1. Location of As-Samra Wastewater Treatment Plant (WWTP). 
As-Samra WWTP was established in 1986 to treat wastewater generated from Amman and Zarqa 
cities using wastewater stabilization ponds (WSPs). The WSPs were replaced by a new plant using 
an activated sludge/extended aeration system and was designed to treat an average flow of 365,000 
m3 per day in 2015. The treated wastewater from As-Samra WWTP is discharged to the King Talal 
Dam. A schematic of the As-Samra WWTP is shown in Figure 2. The selected train included primary 
sedimentation, secondary activated sludge, nitrifying treatment units and disinfection by 
chlorination. 
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Figure 2. Process flow schematic of As-Samra WWTP and sampling points. 
2.2. Chemicals 
Reference materials, metabolites, and labeled standards were obtained from Sigma–Aldrich (St. 
Louis, MO, USA). The solvents used in sample preparation were of high-purity grade (OPTIMA, 
Fisher Scientific, St. Louis, MO, USA). 
2.3. Sample Collection, Preparation, and Extractions 
Four grab samples were collected from the influent and effluent of As-Samra WWTP in 1-L glass 
bottles rinsed with methanol and then washed with type I purified reagent water. All samples were 
stored in a refrigerator under dark conditions at 4 to 8 °C. The extraction process was implemented 
according to the procedure provided by Water Sciences Laboratory at the University of Nebraska–
Lincoln (WSL/UNL) in the United States (USA) [16]. Samples were pre-concentrated using solid 
phase extraction (SPE) directly or within 24 h after collection. The collected samples were firstly 
decanted to remove suspended particles and then filtered through 0.45-micron glass fiber filters using 
a vacuum filtration unit. A polymeric Hydrophilic-Lipophilic Balanced (HLB) Oasis 6CC cartridge 
(#WAT106202,200mg) from Waters Corporation (Milford, MA, USA) was connected to a SPE 
manifold and vacuum pump and was preconditioned by passing 6 mL acetone and 6 mL methanol 
sequentially through the cartridge, followed by 6 mL distilled deionized water (DDI H2O). The 
filtered sample was then pumped via tube to the cartridge using a vacuum manifold system. The 
sample flow through the SPE cartridge was kept at approximately 10 mL/min or less. After the whole 
sample was extracted, the cartridge was rinsed with 5 mL of DDI H2O. Room air was allowed to flow 
through the cartridge by continued suction for a minimum of 5 minutes to help dry the cartridge. All 
cartridges were labeled with the necessary information and separately stored in a clean bag at −20 °C. 
It is important to mention that the total number of collected samples (4) is relatively small compared 
with similar studies reported in the literature, which is considered a limitation in this study. 
2.4. Analytical Methods 
Sample cartridges were eluted and analyzed using liquid chromatography tandem mass 
spectrometry (LC-MS/MS). Cartridges were eluted with 3 mL of high-purity methanol into a 
disposable glass culture tube, followed by addition of internal standards and surrogates. The eluant 
volume was then reduced under a stream of nitrogen at 40 °C to a volume of 80 uL, and mixed with 
320 µL of ammonium formate added to bring the sample volume to 400 µL, vortexed, and then 
transferred to autosampler vials with silane-treated inserts. Eighteen PPCPs were measured, and 
their physical and chemical properties, including pKa, Log of the octanol/water partition coefficient 
(Log Kow), water solubility, and molecular weight are shown in Table 1. Sample processing and 
instrumentation are similar to previously published methods [16–19].  
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Table 1. Classification and physical and chemical properties of target pharmaceuticals and personal 
care products. 
Compound Chemical structure 
Family and 
Use 
pKa 
Log 
Kow 
Water 
Solubility 
mg/L 
Molecular 
Weight 
g/mol 
1,7-
dimethylxanthi
ne a  
Stimulant 9.9 −0.78 1000 180.2 
Acetaminophen 
a  
Analgesic 9.38 0.46 14,000 151.2 
Amphetamine a 
 
Stimulant 10.1 1.76 28000 135.2 
Caffeine a 
 
Stimulant 10.4 −0.07 21,600 194.2 
Carbamazepine 
a  
Anticonvulsan
t 
13.9 2.45 17.7 236.3 
Cimetidine a 
 
Antiacid 6.8 0.40 9380 252.3 
Cotinine a 
 
Stimulant 4.79 0.07 1,000,000 176.2 
Diphenhydrami
ne a  
Antihistamine 8.98 3.27 3060 255.4 
Methylenedioxy 
amphetamine 
(MDA) a  
Abuse drug 9.67 1.64 22,500 179.2 
Methylenedioxy
methamphetamin
e (MDMA) a 
Abuse drug 9.9 2.15 7034 193.3 
Methamphetami
ne a  
Stimulant 9.87 2.07 13,290 149.2 
Morphine a 
 
Narcotic 
analgesic 
8.21 0.89 149 285.3 
Phenazone a 
 
Analgesic 1.4 0.38 51,900 188.2 
Sulfachloropyra
dazine b 
 
Antibacterial 5.7 0.31 8235 284.7 
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Sulfamethazine 
b 
 
Antibacterial 7.45 0.8 1500 278.3 
Sulfamethoxazo
le b 
 
Antibiotic 6.1 0.48 3942 253.3 
Thiabendazole b 
 
Fungicide and 
parasiticide 
4.64 2.47 50 201.2 
Trimethoprim a 
 
Antibiotic 7.12 0.91 400 290.3 
a https://pubchem.ncbi.nlm.nih.gov/ [20] ; b Díaz-Cruz et al. [21]. 
Compound separation was achieved on an Agilent Series 1100 HPLC system (Santa Clara, CA, 
USA) equipped with a Thermo-Scientific C18 embedded column (250 mm × 2.1 mm, particle size 5 
µm). The gradient method was used with 0.5 g/L ammonium formate in water as eluent A and 0.5 
g/L ammonium formate in methanol as eluent B in gradient elution mode at a flow rate of 0.2 mL/min. 
Initial mobile phase conditions were 100:0 A/B for 1 min followed by a linear gradient to attain a 
composition of 60:40 A/B at 10 min, then changing to another linear gradient to reach a composition 
of 5:95 A/B at 18 min. The final composition was held for 10 min before returning to the initial 
conditions. The injection volume was 20 µL. 
Multiple reaction monitoring (MRM) was carried out on an Agilent 6410 triple-quadrupole mass 
spectrometer equipped with an electrospray ionization interface, using the positive-ion mode (Santa 
Clara, CA, USA). The conditions for the analysis were as follows: drying gas temperature, 350 °C; 
capillary voltage, 4.0 kV; drying gas flow, 12 L/min; and nebulizer pressure, 40 psi. The Agilent 
MassHunter software was used for instrument control, data acquisition, and quantitation (Santa 
Clara, CA, USA). 
Method detection limits were determined from the standard deviation of replicate extraction 
and analysis of 8 low-level (0.015 µg/L) fortified blanks and ranged from 0.002 to 0.050 µg/L with 
recoveries ranging from 65% to 185%. Quality controls processed with cartridges included laboratory 
reagent blanks and laboratory fortified blanks included at a rate of 5%. Surrogate recoveries ranged 
from 27% to 127% in sample extracts. 
3. Results 
3.1. Operating Conditions of As-Samra WWTP 
The operating conditions were obtained from the plant and are summarized in Table 2. As-
Samra WWTP has three parallel treatment trains. 
Table 2. Wastewater quality and operating conditions for the influent and effluent in As-Samra 
WWTP during sample collection. 
Sampling 
Date 
Flow 
Rate 
(m3/day) 
Sampling 
Point pH 
Chemical 
Oxygen 
Demand 
(COD), 
(mg/L) 
Biological 
Oxygen 
Demand 
(BOD5), 
(mg/L) 
Total 
Suspended 
Solids 
(TSS), 
(mg/L) 
Total 
Nitrogen 
(T-N), 
(mg/L) 
Total 
Phosphorus 
(T-P), 
(mg/L) 
17 June 
2017 
322246 
Influent 7.29 517 620 480 96 11.4 
Effluent 7.02 127 8 18.0 12.2 2.2 
6 July 
2017 
336045 
Influent 7.11 1183 540 501 98 11.3 
Effluent 7.10 44.5 5 10.0 14.4 6.5 
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The water samples for this study were collected after the grit removal unit (influent) and prior 
to disinfection (effluent). The average flow of As-Samra WWTP was 323,790 m3/day during the 
sampling time. Moreover, the removal efficiency of WWTP for Chemical oxygen Demand (COD), 
Biological Oxygen Demand (BOD5), Total Suspended Solids (TSS), Total Nitrogen (T-N) and Total 
Phosphorus (T-P) is higher than 96%, 99%, 98%, 86%, and 57%, respectively, and the final effluent 
met the requirements of the Jordanian standards (JS893/2006). The wastewater characteristics and 
performance of the WWTP were stable across sampling events with high BOD5/COD removal. The 
plant treats a mixture of domestic, commercial, and industrial wastewater. In comparison with 
regular and similar WWTPs in other regions of USA and Europe, the WWTP in Jordan receives a 
higher concentration of pollutants in raw wastewater (up to 1247 mg/L of COD and up to 98 mg T-
N/L). This is might be caused by the low water consumption in Jordan (68 L/capita/day) as well as 
the discharge of industrial wastewater in the catchment of As-Samra WWTP. 
3.2. Occurrence of PPCPs in WWTP 
The main pathway for the discharge of pharmaceuticals and personal care products (PPCPs) 
into area waterways is through wastewater treatment plants (WWTPs), which are inefficient in 
removing many compounds [7–11]. The results showed that 14 PPCPs were detected in the collected 
samples from the influent and effluent of As-Samra WWTP (Table 3). These compounds are 1,7-
dimethylxanthine, amphetamine, acetaminophen, caffeine, carbamazepine, cimetidine, cotinine, 
diphenhydramine, MDMA, morphine, phenazone, sulfamethazine, sulfamethoxazole, 
thiabendazole, and trimethoprim. However, four PPCPs were below the detection limits (<0.005 
µg/L), namely cimetidine, MDA, methamphetamine, and sulfachloropyridazine. 
The PPCP compound with the highest estimated concentration was caffeine, followed by 
acetaminophen and 1,7-dimethylxanthine. This is not surprising, since all three products are available 
over the counter and used widely. Moreover, it is well documented in the literature that caffeine has 
been detected in surface water worldwide, as it is widely used in a variety of food, beverages, and 
drugs [22]. Caffeine had the highest concentration detected in the present study, with concentrations 
ranging from 128.8 µg/L to 182.5 µg/L. This is consistent with some findings in the literature. 
Actually, caffeine is a hydrophilic compound (log Kow = −0.07) and one the most widely detected 
compounds in wastewater due to the high consumption of foods, beverages, and pharmaceuticals 
containing this substance [23]. Moreover, Rodríguez-Gil et al. [24] reported that the highest caffeine 
concentrations in WWTP influents and effluents are found in the Middle East region, with 
concentrations almost 100 times higher than those estimated in Europe and Asia-Pacific, and 10 times 
higher than those estimated in North America. Like caffeine, its primary metabolite (1,7-
dimetylxanthine or paraxanthine) had the third highest concentration detected in wastewater (10.49 
µg/L). It is well known that 1,7-dimethylxanthine is generated from the human metabolite of caffeine, 
which exists in many products (i.e., coffee, tea, chocolate, etc.). 
Acetaminophen was the second highest compound detected in the raw wastewater (36.7 µg/L). 
This could be due to the huge consumption of cough medicines and painkillers, which are also the 
most abused medications. Actually, acetaminophen (paracetamol) is one of the most popular and 
most commonly used analgesic and antipyretic drugs around the world, available without a 
prescription. It was discovered over 100 years ago and has been widely used in medical practice for 
more than half a century (since 1955). There are about 100 preparations in the market containing 
paracetamol alone or in combination with other active substances [25].  
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Table 3. Concentrations of pharmaceuticals and personal care products detected in collected grab 
(ppb) from As-Samra WWTP. 
PPCPs 
Influent 
Concentration 
(µg/L) 
Average 
Concentr
ation 
(µg/L) 
Effluent 
Concentration (µg/L) Average 
Concentrat
ion (µg/L) 
Efficienc
y 
Removal 17 June 
2017 
6 July 
2017 
17 June 
2017 
6 July 
2017 
1,7-
Dimethylxan
thine 
7.47 13.5 10.49 0.018 0.009 0.014 99.9 
Acetaminoph
en 
28.7 44.7 36.7 0.038 0.044 0.041 99.9 
Amphetamin
e 
0.005 0.252 0.129 0.014 0.037 0.026 80.2 
Caffeine 182.5 128.8 155.6 0.092 0.08 0.086 99.9 
Carbamazepi
ne 1.54 0.67 1.104 0.831 0.881 0.856 22.5 
Cimetidine <0.005 <0.005 <0.005 <0.005 <0.005 <0.005  
Cotinine 4.67 5.29 4.98 0.030 0.125 0.078 98.4 
Diphenhydra
mine 
<0.005 <0.005 <0.005 0.061 0.026 0.044 –770.0 
MDA <0.005 <0.005 <0.005 <0.005 <0.005 <0.005 0.0 
MDMA 0.018 <0.005 0.012 <0.005 <0.005 <0.005 56.5 
Methamphet
amine 
<0.005 <0.005 <0.005 <0.005 <0.005 <0.005  
Morphine 0.042 0.049 0.046 <0.005 <0.005 <0.005 89.0 
Phenazone 0.042 0.032 0.037 0.017 <0.005 0.011 70.3 
Sulfachlorop
yridazine 
<0.005 <0.005 <0.005 <0.005 <0.005 <0.005  
Sulfamethazi
ne 0.021 0.116 0.069 0.052 0.034 0.043 37.2 
Sulfamethox
azole 0.349 <0.005 0.177 0.161 0.031 0.096 45.8 
Thiabendazo
le 
0.012 0.017 0.015 0.013 0.021 0.017 −17.2 
Trimethopri
m 0.128 0.213 0.171 <0.005 <0.005 <0.005 97.1 
% Removal = (influent − effluent)/influent × 100. 
3.3. Removal Efficiency of PPCPs in WWTP 
The results showed that the levels of PPCPs in the wastewater effluent were lower than in the 
raw influent, indicating that the majority of compounds can be at least partially removed by the 
activated sludge system used at As-Samra WWTP. Table 3 shows that the removal efficiencies vary 
greatly, with the lowest values (≤50%) for carbamazepine, sulfamethazine, sulfamethoxazole, and 
thiabendazole, and the highest values (>98%) for 1,7-dimethylxanthine, acetaminophen, caffeine, and 
cotinine. However, a moderate removal efficiency (70.3%) was shown for phenazone. Previous 
studies have demonstrated that the removal efficiency for pharmaceutical ingredients can vary for 
different wastewater treatment technologies and even for a given method [26,27]. Wastewater 
treatments are usually divided into primary, secondary, and tertiary treatment systems [26]. The 
treatment process at As-Samra is considered to be a secondary wastewater treatment system. The 
removal efficiencies for PPCPs found in this plant were consistent with results reported for secondary 
treatment systems worldwide [28,29]. However, to improve removal, a tertiary treatment system 
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such as advanced oxidation can remove these compounds completely, but these methods are very 
expensive to apply in big wastewater treatment plants [30]. 
The highest removal efficiencies of PPCPs were recorded for caffeine (99.9%), acetaminophen 
(99.9%), 1,7-dimethylxanthine (99.9%), and cotinine (98.4%). The removal efficiency of these 
compounds was very high (>98.4%) among the target compounds. It is well known that physical and 
chemical properties of PPCPs play an important role in their transport and removal in the wastewater 
treatment process. A plot of removal efficiency vs. Log of the octanol/water partition coefficient (Log 
Kow) showed a relationship for most of the compounds (R-squared = ~0.71), with the removal 
efficiency increasing as the Log Kow value decreased. For example, caffeine, 1,7-dimethylxanthine, 
and acetaminophen were found to be the most hydrophilic (Log Kow < 1.0) and the most water soluble 
(water solubility > 1000 mg/L) among the target compounds (Table 2). Therefore, due to the high 
water solubility and low Log Kow, removal of these compounds by a sorption mechanism is unlikely 
to occur [31]. Moreover, biodegradation is considered to be a major removal mechanism for these 
hydrophilic compounds [32,33]. Batt et al. (2007) concluded that the removal of caffeine, among other 
organic micropollutants in wastewater, is dependent on a combination of biological and 
physicochemical treatment [34]. An efficient removal of caffeine, as that observed in the present 
study, has also been reported using other biological treatment systems such as slow sand filters [35]. 
Moreover, the results clearly showed that two PPCPs (carbamazepine and thiabendazole) were 
relatively unchanged after the treatment process at As-Samra WWTP. The water solubility of these 
compounds is very low (17 mg/L and 50 mg/L, respectively) compared with other compounds. 
Radjenovic et al. (2007) also reported poor biodegradability of carbamazepine in biological 
wastewater treatment systems (e.g., active sludge systems) [36]. The low water solubility of these 
compounds is believed to be an important factor of its resistance to treatment. Therefore, these 
compounds are used as effluent tracer compounds in the environment. In addition, the removal 
efficiency of thiabendazole had a negative value, which resulted from a higher concentration in the 
effluent than in the influent of the WWTP. Many studies have reported a negative removal efficiency 
for PPCPs that is caused by transformation, recombination, and/or accumulation of compounds 
during secondary treatment [11,37,38]. Moreover, As-Samra Wastewater Treatment Plant (WWTP) is 
the largest wastewater treatment facility in Jordan, which is located at Amman Zarqa Basin (AZB). 
Its annual average discharge is about 118 × 106 m3 of treated wastewater, which runs in the Zarqa 
river and is finally stored at King Talal Dam (KTD). A recent study showed that an analysis of the 
same 18 PPCPs in surface water samples at KTD revealed the persistent presence of these compounds 
in KTD water with the same distribution as in effluent samples from As-Samra WWTP [39]. This 
study suggests that it is likely that WWTPs operating in AZB watersheds do not completely remove 
PPCPs compounds, causing the transportation of these compounds to this important aquatic 
ecosystem [39]. 
3.4. Comparison with Existing Studies 
Among all PPCPs analyzed in the current study, acetaminophen, caffeine, cotinine, and 
carbamazepine had the highest concentrations in the influent and effluent of As-Samra wastewater 
treatment plants. These concentrations were also found to be comparable with concentrations 
measured in domestic wastewater in India and USA (Figure 2a,b) [40,41], and higher than those 
reported in Greece and Vietnam [42,43]. As for acetaminophen, it is one of the medicines sold all over 
the world without the need for prescription. This is because of its mild effects on the human body 
compared to other analgesic substances (e.g., diclofenac) and its high biodegradability in the 
environment. Differently, caffeine is not a medicine but a stimulant that is widely consumed in 
stimulant drinks such as coffee and soft drinks. The concentrations of PPCPs released by WWTPs 
into the environment exhibit great variability, leading to inconclusive results [11]. This is mainly due 
to the large number of variables involved in the behavior and transport of PPCPs from their sources 
to the discharging point of WWTP, including fluctuations in consumption patterns, physicochemical 
properties of these compounds, differing conditions in WWPT plants, influent concentration in 
WWTPs, sewage composition, and plant operating parameters. 
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Figure 2. Concentrations of acetaminophen, caffeine, carbamazepine, and continine (ng/L) in Influent 
(a) and Effluent (b) of wastewater treatment plants (India, Balakrishna et al. [40]; Greece, 
Papageorgiou et al. [41], USA, Lubliner & Melanie [42]; Vietnam, Nguyen et al. [43]). 
Removal efficiency rates of the PPCPs in As-Samra WWTP were generally consistent with those 
of indicator compounds reported in the literature for conventional WWTPs. For instance, the removal 
efficiency of carbamazepine observed in this study is comparable to those reported in WWTPs using 
an activated sludge process [9]. Moreover, many studies have reported that carbamazepine is 
recalcitrant in the environment and during wastewater treatment, which is mainly due to the lowest 
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sorption and biodegradability in wastewater treatments [44,45]. Although data exists on the 
occurrence and removal of PPCPs during WWTPs worldwide (Europe, USA, Canada, and Asia), to 
the best of our knowledge, scarce data are currently available on the occurrence and removal of these 
compounds in WWTPs located in the Middle East and North Africa (MENA region). Actually, the 
research efforts made to address this issue in the MENA region is still lagging behind those in 
developed countries due to lack of monitoring of PPCP compounds in water resources as well as lack 
of availability of the analytical instruments and methods needed to identify PPCPs at low 
concentration levels (ng/L). 
4. Conclusions 
Nine PPCPS were detected in the samples collected from the influent and effluent of As-Samra 
WWTP, namely 1,7-dimethylxanthine, acetaminophen, caffeine, carbamazepine, cimetidine, cotinine, 
phenazone, sulfamethazine, sulfamethoxazole, and thiabendazole. 1,7-Dimethylxanthine, 
acetaminophen, and caffeine had the highest average concentrations in raw wastewater due to their 
high over-the-counter availability and wide use. However, the highest average concentrations 
detected in treated wastewater were for carbamazepine, sulfamethoxazole, caffeine, and cotinine. 
This study clearly showed that incomplete removal and/or degradation of PPCPs takes place in As-
Samra WWTP. Therefore, a monitoring campaign should be implemented to evaluate the occurrence 
and removal of PPCPs in As-Samra WWTP over the four seasons. Moreover, there is a lot of scientific 
research and information regarding the chemistry, toxicity, and fate of pharmaceutical contaminants 
in wastewater treatment plants. Most of these research efforts have focused on removing these 
contaminants from the effluent wastewater. However, less effort has been made to minimize the 
levels of these contaminants at their sources, especially at home, pharmacies, and hospitals. 
Therefore, there is a need in Jordan to raise public awareness about the impact of these contaminants 
on water and the food cycle. This awareness will help the local authorities to implement any future 
policies that cover pharmaceutical waste management and handling at home, pharmacies, and 
hospitals. 
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